The autoinjector market is expected to register a substantial growth in the future, owing to rise in anaphylaxis cases. In addition, rise in R&D efforts by companies to develop simple, cost effective, and new technology based autoinjectors for treatment of chronic diseases such as rheumatoid arthritis and multiple sclerosis is expected to boost the market growth during the forecast period.